Neuroprotective Supplement Composition for High-Dose Cognitive Support

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing neuroprotective supplements contain insufficient dosages of N-acetylcysteine, glycine, choline, and biotin, failing to provide synergistic neuroprotective effects and cognitive benefits for patients with neurodegenerative conditions.

Innovation Solution

A supplement formulation comprising N-acetylcysteine, glycine, choline, and biotin in daily dosages exceeding traditional multivitamin levels, tailored through biomarker testing for individual patient needs, administered in personalized protocols.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional multivitamin formulations are used, then the supplement contains numerous other compounds, but the dosage of N-acetylcysteine, glycine, choline, and biotin is insufficient to provide synergistic neuroprotective effects

Engineering Contradiction:

Improvedosage of neuroprotective compoundsVSAvoidformulation complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts and isolates the four key neuroprotective compounds (N-acetylcysteine, glycine, choline, and biotin) from complex multivitamin formulations to create a focused supplement that delivers therapeutically effective dosages without the dilution effect of numerous other ingredients

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent combines four specific compounds in defined proportions to create a composite supplement formulation that leverages their synergistic neuroprotective effects, with each compound contributing specific functions (glutathione production, neurotransmitter synthesis, membrane integrity, and metabolic support)

Inventive Principle:

Principle #40Composite materials

2Reliability

If N-acetylcysteine and glycine are combined, then glutathione production is promoted, but the dosage must be high enough to overcome age-related diminishment

Engineering Contradiction:

Improveneuroprotective efficacyVSAvoiddosage requirement

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent increases the dosage parameters of N-acetylcysteine and glycine from typical multivitamin levels to therapeutically effective ranges (e.g., 500-2000 mg per compound daily) to ensure sufficient substrate availability for glutathione synthesis in aging brains where endogenous production declines

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent provides high-dosage N-acetylcysteine and glycine in advance to build and maintain glutathione reserves before neurodegenerative damage occurs, rather than attempting to treat established conditions

Inventive Principle:

Principle #10Preliminary action

3Adaptability or versatility

If choline is added to support neurotransmitter production and membrane integrity, then brain development and nervous system function are supported, but the dosage must exceed traditional multivitamin levels

Engineering Contradiction:

Improvecognitive benefitVSAvoiddosage level

Core Design Contradiction:

Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent targets specific neurological functions with appropriate dosages of choline (e.g., 250-1000 mg daily) to support acetylcholine synthesis and phospholipid membrane integrity in brain tissue, rather than providing minimal amounts in general multivitamins

Inventive Principle:

Principle #3Local quality

4Use of energy by moving object

If biotin is included for energy production and metabolic support, then neurological function is supported, but traditional formulations provide insufficient dosage

Engineering Contradiction:

Improveenergy productionVSAvoiddosage amount

Core Design Contradiction:

Use of energy by moving objectVSQuantity of substance

Solution Approach 1:

The patent includes biotin at elevated dosages (e.g., 100-1000 mcg daily) to support multiple neurological functions simultaneously: energy production via carboxylase enzymes, fatty acid synthesis for membrane repair, and amino acid metabolism for neurotransmitter precursors

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260069561A1Neuroprotective supplements

Publication Date: 2026.03.12 ACHARI MD MADHUREETA

AI summary

A supplement, and a method of treatment utilizing the supplement to elicit positive responses in a patient with neurological conditions is disclosed. The supplement comprises four components: N-acetylcysteine, glycine, choline, and biotin. In the preferred embodiment for treating adult patients, the effective supplement daily dosage comprises at least 1500 mg of glycine, 1500 mg of N-acetylcysteine, 1000 mg of choline, and 1000 μg of biotin. In another embodiment for treating pediatric patients, the supplement may comprise an effective supplement daily dosage of at least 500 mg of glycine, 500 mg of N-acetylcysteine, 250 mg of choline, and 250 μg of biotin. In a method embodiment, regular daily dosages of a supplement comprising over 1 g total of the four components are administered, resulting in improved outcomes among patients with cognitive impediments.